Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation
Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation
复制标题
DOI:
10.1016/s0090-6980(98)00077-x
复制
发表时间:
1999-07-01
影响因子:
2.9
通讯作者:
Liu, WG
中科院分区:
文献类型:
--
作者:
Harada, N;Okajima, K;Liu, WG
We investigated whether, in rats, gastric prostacyclin (PGI(2)) prevented gastric mucosal injury that was induced by water-immersion restraint stress by inhibiting leukocyte activation. Gastric levels of 6-keto-PGF(1)alpha, a stable metabolite of PGI(2), increased transiently 30 min after stress, followed by a decrease to below the baseline 6-8 h after stress. Gastric mucosal blood flow decreased to similar to 40% of the baseline level 8 h after stress. Myeloperoxidase activity was significantly increased 8 h after stress. Treatment with indomethacin before stress inhibited the increase in 6-keto-PGF(1)alpha levels and markedly reduced mucosal blood flow. It also markedly increased leukocyte accumulation and mucosal lesion formation. Iloprost, a stable PGI(2) analog, inhibited the indomethacin-induced decrease in mucosal blood flow, mucosal lesion exacerbation, and increase in leukocyte accumulation Nitrogen mustard-induced leukocytopenia inhibited the indomethacin-associated lesion exacerbation and the increase in leukocyte accumulation, but not the decreases in mucosal blood how. These observations indicate that gastric PGI(2) decreases gastric mucosal lesion formation primarily by inhibiting leukocyte accumulation. (C) 1999 Elsevier Science Inc. All rights reserved.